FDA label
What is Byfavo used for?
Byfavo contains remimazolam. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “BYFAVO® is indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Byfavo?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Byfavo, injection, powder, lyophilized, for solution
Indications and Usage, quoted from the label by Acacia Pharma, Ltd. (NDA212295). Cross-references to other label sections are left out.
BYFAVO® is indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.
Source: DailyMed label, set id 4e1838f2-b999-41a7-a761-d94f09aa531f, version 9, effective February 20, 2025. NDC 71390-011, one of 1 listing for this product.
Questions
What is Byfavo used for?
The FDA label says: “BYFAVO® is indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.